Skip to main content
. 2014 Oct;58(10):6116–6121. doi: 10.1128/AAC.02972-14

TABLE 3.

Common drug-related adverse events in the single-dose PK study of i.v. nemonoxacin

Adverse event No. (%) of subjects with indicated adverse event at a nemonoxacin dosage ofa:
250 mg (n = 12) 500 mg (n = 12) 750 mg (n = 11)
Injection site reaction 3 (25) 4 (33) 7 (64)
Erythematous rash 0 (0) 1 (8) 2 (18)
Total 3 (25) 5 (42) 9 (82)
a

The infusion rate for each group was 5.56 mg/min.